Table 1.

Comparison of VEGF-B, VEGF-C, VEGF, and β-Actin mRNA Expression in Human Tumors

Tumor	mRNA
	VEGF-B	VEGF-C	VEGF	β-Actin
Adenocarcinoma	−	−	−	++
Primary Metastasis	+	+	+	++
Breast carcinoma
Ductal Grade 1	−	−	−	++
Grade 2	++	++	−	++
Grade 3	+	+	+++>	+++
Grade 3	+	−	−	+
Grade 3	−	−	−	++
Grade 3	−	−	−	++
Grade 3	++	−	+	++
Grade 3	++	++	++	+++
Breast carcinoma, lobular	++	+	NT	NT
Breast carcinoma, intraductal (large)	++	−	++	NT
Squamous cell carcinoma
Primary	++	+	+	++
Primary	+	++	++	++
Primary	+	+	−	+++
Primary	+	+++	NT	+
Metastasis	+	−	−	++
Metastasis	++	++	+	+++
Metastasis	+	−	NT	++
Lymphoma
Non-Hodgkin	+++	+	−	++
Non-Hodgkin	++	+	+	++
Non-Hodgkin	++	+	NT	+
Melanoma
Primary	+++	+++	+++	+++
Metastasis	+	−	−	++
Metastasis	+++	++	++	++
Metastasis	+++	−	NT	++
Metastasis	++	−	+	+
Sarcoma
Fibrosarcoma	+++	+++	+	++
Schwannoma	+++	−	−	++
MFH	++	++	+++	++
NUD	+	+	−	+++
Head and neck tumor
Benign adenoma (from salivary glands)	+	−	+	++
Benign papilloma	+	−	+	++
Benign papilloma	+	−	+	++
Benign thymoma	++	+	++	++

NT, not tested; NUD, not determined, MFH, malignant fibrous histiocytoma.